Cargando…
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
In recent years, cancer immunotherapy based on immune checkpoint inhibitors (ICIs) has achieved considerable success in the clinic. However, ICIs are significantly limited by the fact that only one third of patients with most types of cancer respond to these agents. The induction of cell death mecha...
Autores principales: | Tang, Rong, Xu, Jin, Zhang, Bo, Liu, Jiang, Liang, Chen, Hua, Jie, Meng, Qingcai, Yu, Xianjun, Shi, Si |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418434/ https://www.ncbi.nlm.nih.gov/pubmed/32778143 http://dx.doi.org/10.1186/s13045-020-00946-7 |
Ejemplares similares
-
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
por: Tong, Xuhui, et al.
Publicado: (2022) -
The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer
por: Tang, Rong, et al.
Publicado: (2020) -
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
por: Gao, Weitong, et al.
Publicado: (2022) -
Ferroptosis, pyroptosis and necroptosis in acute respiratory distress syndrome
por: Zheng, Yongxin, et al.
Publicado: (2023) -
Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases
por: Cai, Yuxi, et al.
Publicado: (2022)